Atlas Trials

Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer

Clinical trial NCT02838381 · COMPLETED

Trial details

NCT number
NCT02838381
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2012-06-01
Primary completion
2023-12-31
Enrollment
553

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.